Oral administration of 5-ALA

4 trials

Sponsors

Gohda Yoshimasa, Department of Neurosrugery, Osaka University Hospital, Department of Neurosurgery, Kobe University Hospital

Conditions

Brain tumorsPseudomyxoma Peritonei pseudomyxoma peritonei 5-ALAmalignant tumor of central nervous systemperitoneal metastasis from colorectal cancer peritoneal metastasis from colorectal cancer, 5-ALA

Phase 2

Diagnosis of peritoneal metastasis with 5-aminolevulinic acid for pseudomyxoma peritonei

Active, not recruitingJPRN-jRCTs031190042

Gohda YoshimasaPseudomyxoma Peritonei pseudomyxoma peritonei 5-ALA

Start: 2019-06-20Target: 30Updated: 2026-06-29

RecruitingJPRN-jRCTs031200038

Gohda Yoshimasaperitoneal metastasis from colorectal cancer peritoneal metastasis from colorectal cancer, 5-ALA

Start: 2020-05-28Target: 20Updated: 2026-06-29

Unknown Phase

Biological assessment for brain tumors in 5-ALA-induced fluorescence-guided surgery

Active, not recruitingJPRN-UMIN000005617

Department of Neurosrugery, Osaka University HospitalBrain tumors

Start: 2011-01-13Target: 75Updated: 2026-06-29

The study of fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant central nervous system tumor.

Active, not recruitingJPRN-UMIN000007872

Department of Neurosurgery, Kobe University Hospitalmalignant tumor of central nervous system

Start: 2012-09-01Target: 90Updated: 2026-06-29